90 related articles for article (PubMed ID: 22319837)
1. [Chemotherapy for breast cancer].
Nakayama T; Noguchi S
Gan To Kagaku Ryoho; 2011 Dec; 38(13):2569-73. PubMed ID: 22319837
[No Abstract] [Full Text] [Related]
2. Breast cancer gene microarrays pass muster.
Twombly R
J Natl Cancer Inst; 2006 Oct; 98(20):1438-40. PubMed ID: 17047189
[No Abstract] [Full Text] [Related]
3. The use of microarray technology in the management of breast cancer.
Pusztai L
Clin Adv Hematol Oncol; 2007 Mar; 5(3):193-4, 197. PubMed ID: 17519880
[No Abstract] [Full Text] [Related]
4. The use of genomic tools for the molecular understanding of breast cancer and to guide personalized medicine.
Foekens JA; Wang Y; Martens JW; Berns EM; Klijn JG
Drug Discov Today; 2008 Jun; 13(11-12):481-7. PubMed ID: 18549973
[TBL] [Abstract][Full Text] [Related]
5. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?
Correa Geyer F; Reis-Filho JS
Int J Surg Pathol; 2009 Aug; 17(4):285-302. PubMed ID: 19103611
[TBL] [Abstract][Full Text] [Related]
6. Re: Breast cancer gene microarrays pass muster.
Shak S; Palmer G; Baker J
J Natl Cancer Inst; 2007 Apr; 99(7):572-3. PubMed ID: 17406004
[No Abstract] [Full Text] [Related]
7. C-kit expression in high-risk breast cancer subgroup treated with high-dose or conventional dose-dense chemotherapy.
Diallo R; Ting E; Gluz O; Herr A; Schütt G; Geddert H; Mohrmann S; Gabbert HE; Nitz U; Poremba C
Verh Dtsch Ges Pathol; 2006; 90():177-85. PubMed ID: 17867595
[TBL] [Abstract][Full Text] [Related]
8. Genetic profiling can predict chemotherapy side effects and treatment response.
Expert Rev Mol Diagn; 2003 Jul; 3(4):406-7. PubMed ID: 12877380
[No Abstract] [Full Text] [Related]
9. Economic analysis of gene expression profile data to guide adjuvant treatment in women with early-stage breast cancer.
Cosler LE; Lyman GH
Cancer Invest; 2009 Dec; 27(10):953-9. PubMed ID: 19909009
[No Abstract] [Full Text] [Related]
10. Translational research in breast cancer.
Chu QD; Holm N; Byrnes K; Li BD
Surg Oncol Clin N Am; 2008 Apr; 17(2):421-38, x. PubMed ID: 18375360
[TBL] [Abstract][Full Text] [Related]
11. [The value of gene expression profiles using micoarrays for the individualisation of adjuvant therapy after surgery for breast cancer].
Klijn JG; de Vries EG
Ned Tijdschr Geneeskd; 2005 Mar; 149(12):618-22. PubMed ID: 15813427
[TBL] [Abstract][Full Text] [Related]
12. Multiple gene signatures aim to qualify risk in breast cancer.
Tuma RS
J Natl Cancer Inst; 2005 Mar; 97(5):332. PubMed ID: 15741566
[No Abstract] [Full Text] [Related]
13. Taxanes and gene expression in breast cancer cells.
Rzymowska J; Maj P; Niemczyk M; Malewski T; Wilkołaski A
Acta Pol Pharm; 2008; 65(1):153-7. PubMed ID: 18536190
[TBL] [Abstract][Full Text] [Related]
14. Molecular assays to predict prognosis of breast cancer.
Paik S
Clin Adv Hematol Oncol; 2007 Sep; 5(9):681-2. PubMed ID: 17982408
[No Abstract] [Full Text] [Related]
15. Integrated gene expression profile predicts prognosis of breast cancer patients.
Li LF; Xu XJ; Zhao Y; Liu ZB; Shen ZZ; Jin WR; Shao ZM
Breast Cancer Res Treat; 2009 Jan; 113(2):231-7. PubMed ID: 18278552
[TBL] [Abstract][Full Text] [Related]
16. Gene expression-based diagnosis of efficacy of chemotherapy for breast cancer.
Miki Y
Breast Cancer; 2010 Apr; 17(2):97-102. PubMed ID: 20013078
[TBL] [Abstract][Full Text] [Related]
17. The value of genomic analysis of breast cancer in drug development.
Szekely B; Pusztai L
J Natl Cancer Inst Monogr; 2011; 2011(43):60-2. PubMed ID: 22043042
[TBL] [Abstract][Full Text] [Related]
18. Genomic medicine. Gene expression tests foretell breast cancer's future.
Garber K
Science; 2004 Mar; 303(5665):1754-5. PubMed ID: 15031473
[No Abstract] [Full Text] [Related]
19. DNA repair signature is associated with anthracycline response in triple negative breast cancer patients.
Rodriguez AA; Makris A; Wu MF; Rimawi M; Froehlich A; Dave B; Hilsenbeck SG; Chamness GC; Lewis MT; Dobrolecki LE; Jain D; Sahoo S; Osborne CK; Chang JC
Breast Cancer Res Treat; 2010 Aug; 123(1):189-96. PubMed ID: 20582464
[TBL] [Abstract][Full Text] [Related]
20. cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance.
Villeneuve DJ; Hembruff SL; Veitch Z; Cecchetto M; Dew WA; Parissenti AM
Breast Cancer Res Treat; 2006 Mar; 96(1):17-39. PubMed ID: 16322897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
